润都股份：缬沙坦氨氯地平片(I)获得药品注册证书

Core Viewpoint - The company, Rundu Co., Ltd. (002923.SZ), has received a drug registration certificate from the National Medical Products Administration for Valsartan Amlodipine Tablets, which is indicated for the treatment of primary hypertension in patients whose blood pressure is not adequately controlled with monotherapy [1] Group 1 - The drug Valsartan Amlodipine Tablets is specifically designed for patients with primary hypertension [1] - The approval signifies a potential expansion in the company's product offerings in the hypertension treatment market [1]